Pulmatrix Inc (PULM): The significance of the licensing deal:...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	51
Posts	3078
Boards Moderated	0
Alias Born	05/11/2016

3DYOGI

Re: None

Thursday, 09/07/2017 9:58:40 PM

Thursday, September 07, 2017 9:58:40 PM

The significance of the licensing deal: Validation of its iSperse Technology to support its lead assets: PUR1900 & PUR1800.

http://www.pulmatrix.com

5 X more effective , 15% of $3 Billion = $450 Million or $22.50 EPS. and that's just the US market.

Cystic Fibrosis foundation is a huge deal...

Over 50% of the float is owned by insiders and Inst. Only 20 Million shares outstanding less than 10 million floating...

PULM founders
David Edwards, PhD Professor of Biomedical Engineering, Harvard University
Mark Gabrielson Owner and General Partner, p-Value Capital
Alexander Klibanov, PhD Professor of Chemistry and Bioengineering, MIT
Robert Langer, PhD Professor of Chemical and Biomedical Engineering, MIT

$PULM

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PULM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 02:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:05:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 01:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:05:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:05:21 PM